ReviewInternational journal of clinical practice2014

GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?

S BruntonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.